Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies

Immune Engaging Molecules in the Management of Lymphoid Malignancies

View Workshop (ASH registration required)

Program

Current Results with BITEs and Bispecific Antibodies in Lymphoid Malignancies

Max S. Topp MD

Universitätsklinikum Würzburg

 

BIKEs TRIKEs and SMITEs

Jeffrey S. Miller MD

University of Minnesota

 

CD19 Antibodies and CD79-Directed ADCs in B-cell Malignancies

Laurie H. Sehn MD MPH

BCCancer and The University of British Columbia

 

Immune Engaging Molecules in the Management of Lymphoid Malignancies

Stephen M. Ansell MD PhD

Mayo Clinic

 

Immune Engaging Molecules in the Management of Lymphoid Malignancies

Ronald Levy MD

Stanford University Medical Center